Literature DB >> 19883201

Extracellular matrix isolated from foreskin fibroblasts supports long-term xeno-free human embryonic stem cell culture.

Guoliang Meng1, Shiying Liu, Xiangyun Li, Roman Krawetz, Derrick E Rancourt.   

Abstract

Human embryonic stem (hES) cells hold great promise for application of human cell and tissue replacement therapy. However, the overwhelming majority of currently available hES cell lines have been directly or indirectly exposed to materials containing animal-derived components during their derivation, propagation, and cryopreservation. Unlike feeder-based cultures, which require the simultaneous growth of feeder and stem cells, resulting in mixed cell populations, stem cells grown on feeder-free systems are easily separated from the surface, presenting a pure population of cells for downstream applications. In this study, we have developed a novel method to expand hES cells in xeno-free, feeder-free conditions using 2 different matrices derived from xeno-free human foreskin fibroblasts (XF-HFFs). Using XF-HFF-derived extracellular matrix, together with 100 ng/mL recombinant bFGF-supplemented HEScGRO Basal Medium, long-term xeno-free expansion of hES cells is possible. Resulting hES cells were subjected to stringent tests and were found to maintain ES cell features, including morphology, pluripotency, stable karyotype, and expression of cell surface markers, for at least 20 passages. Xeno-free culturing practices are essential for the translation of basic hES cell research into the clinic. Therefore, the method presented in this study demonstrates that hES cells can be cultured in complete xeno-free conditions without the loss of pluripotency and furthermore, without the possibility of contamination from exogenous sources.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19883201     DOI: 10.1089/scd.2009.0303

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  13 in total

1.  H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.

Authors:  Hadas Hezroni; Itai Tzchori; Anna Davidi; Anna Mattout; Alva Biran; Malka Nissim-Rafinia; Heiner Westphal; Eran Meshorer
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

2.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

Authors:  Emma Stephenson; Laureen Jacquet; Cristian Miere; Victoria Wood; Neli Kadeva; Glenda Cornwell; Stefano Codognotto; Yaser Dajani; Peter Braude; Dusko Ilic
Journal:  Nat Protoc       Date:  2012-06-21       Impact factor: 13.491

3.  Development of a simple, repeatable, and cost-effective extracellular matrix for long-term xeno-free and feeder-free self-renewal of human pluripotent stem cells.

Authors:  Mohammad Pakzad; Mohammad Kazemi Ashtiani; Seyed Latif Mousavi-Gargari; Hossein Baharvand
Journal:  Histochem Cell Biol       Date:  2013-09-25       Impact factor: 4.304

Review 4.  Substrates and supplements for hESCs: a critical review.

Authors:  Melisa Candela Crocco; Nilo Fratnz; Adriana Bos-Mikich
Journal:  J Assist Reprod Genet       Date:  2013-01-04       Impact factor: 3.412

5.  Human pluripotent stem cells: from biology to cell therapy.

Authors:  Jean-Marie Ramirez; Qiang Bai; Marilyne Dijon-Grinand; Said Assou; Sabine Gerbal-Chaloin; Samir Hamamah; John De Vos
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

Review 6.  Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.

Authors:  Yongjia Fan; Jincheng Wu; Preeti Ashok; Michael Hsiung; Emmanuel S Tzanakakis
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

7.  The co-injection of somatic cells with embryonic stem cells affects teratoma formation and the properties of teratoma-derived stem cell-like cells.

Authors:  Seung Pyo Gong; Boyun Kim; Hyo Sook Kwon; Woo Sub Yang; Jae-Wook Jeong; Jiyeon Ahn; Jeong Mook Lim
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

8.  Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells.

Authors:  Hayato Fukusumi; Tomoko Shofuda; Daisuke Kanematsu; Atsuyo Yamamoto; Hiroshi Suemizu; Masato Nakamura; Mami Yamasaki; Masatoshi Ohgushi; Yoshiki Sasai; Yonehiro Kanemura
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 9.  Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.

Authors:  Xuemei Fu; Yang Xu
Journal:  Genome Med       Date:  2012-06-28       Impact factor: 11.117

10.  Effects of Human Fibroblast-Derived Extracellular Matrix on Mesenchymal Stem Cells.

Authors:  Yaxian Zhou; Michael Zimber; Huihua Yuan; Gail K Naughton; Ryan Fernan; Wan-Ju Li
Journal:  Stem Cell Rev Rep       Date:  2016-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.